Use of membrane vesicles to investigate drug interactions with transporter proteins, P-glycoprotein and multidrug resistance-associated protein

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 3, 2000, Pages 122-129

  Wheeler, R ^a   Neo, S Y ^a   Chew, J ^a   Hladky, S B ^a   Barrand, M A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Membrane vesicles; Multidrug resistance associated protein; P glycoprotein

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; ETACRYNIC ACID; GLUTATHIONE; GLYCOPROTEIN P; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN; TRITIUM; VERLUKAST; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; ISOTOPE LABELING; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; OSMOTIC STRESS;

EID: 0034010630     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38122     Document Type: Article

References (16)

1. Dale IL, Tuffley W, Callaghan R et al 1998 Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. Br J Cancer 78: 885-892
2. Draper MP, Martell RL, Levy SB 1997 Indomethacin mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br J Cancer 75: 810-815
3. Duffy CP, Elliott CJ, O'Connor RA et al 1998 Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDS). Eur J Cancer 34: 1250-1259
4. Horio M, Gottesman MM, Pastan I 1988 ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Nat Acad Sci USA 85: 3580-3584
5. 3H) vinblastine transport by isolated vesicles. Biochim Biophys Acta 1061: 106-110
6. 2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. J Biol Chem 264: 17343-17348
7. Ishikawa T, Muller M, Klunemann C et al 1990 ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem 265: 19279-19286
8. Ishikawa T, Wright CD, Ishizuka H 1994 GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(ii)-resistant human leukemia HL-60 cells and down-regulated by cell-differentiation. J Biol Chem 269: 29085-29093
9. Jones TR, Zamboni R, Belley M et al 1989 Pharmacology of L-660,711 (MK-571): A novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 67: 17-28
10. Leier I, Jedlitschky G, Buchholz U et al 1994 The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810
11. Loe DW, Deeley RG, Cole SPC 1998 Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione. Cancer Res 58: 5130-5136
12. Neo S-Y, Bagrij T, Hladky SB et al 1997 Characteristics of drug uptake into vesicles containing the multidrug resistance associated protein, MRP. Br J Pharmacol 120: 340P
13. Neo SY 1997 The role of multidrug resistance-associated protein in drug transport. Pharmacology. University of Cambridge, Cambridge
14. Soszynski M, Kaluzna A, Rychlik B et al 1998 Radiation inactivation suggests that human multidrug resistance-associated protein 1 occurs as a dimer in the human erythrocyte membrane. Arch Biochem Biophys 354: 311-316
15. Stewart AJ, Dale IL, Mistry P et al 1997 Characterization of a novel P-glycoprotein inhibitor. XR9051, in human MDR cell lines. Proc Am Assoc Cancer Res, p 3978
16. Wheeler RD, Stewart A, Charlton P et al 1999 Inhibition of vincristine uptake into P-glycoprotein-containing vesicles by the resistance modifier, XR9051. Br J Pharmacol 126: 164P